Acute myeloid leukemia and myeloproliferative syndromes, therapy-related Flashcards
Acute myeloid leukemia and myeloproliferative syndromes
⮚ Most commonly about years later
a. 7
b 5
c.8
d.10
b 5
4) Acute myeloid leukemia and myeloproliferative syndromes, therapy-rela
TRUE OR FALSE
Whether during MDS phase or when it develops into an AML, these patients usually have dysplasia in all cell lines
TRUE
therapy-related
AML AND ML
A. Topoisomerase type II inhibitor-related
B.Topoisomerase type III inhibitor-related
A. Topoisomerase type II inhibitor-related
Occurs after therapy with topoisomerase II inhibitors, such as
A. etoposide and doxorubicin
B. BCR/ABR AND n (RAEB-t)
C. ANKYLATING
D.etoposide and doxorticin
A. etoposide and doxorubicin
**The average interval between treatment and AML is about _ monthsusually without an intervening MDS phase **
a. 33 months
b 12 months
c. 14 months
a. 33 months
